DTU BIOENGINEERING Department of Biotechnology and Biomedicine
Bygningstorvet
Building 116, room 118C
2800 Kgs. Lyngby
Request a vCard via e-mail.
Researchers from DTU Biosustain have successfully produced mammalian cell lines (CHO) that can produce 1.2 g/L recombinant Alpha-1-antitrypsin proteins with human glycosylation profiles. This work can lead to better treatment of the genetic disease Alpha-1 antitrypsin deficiency and avoid dependency of blood donors.